JW Pharmaceutical Corporation (KRX:001065)

JW Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	512,450	561,695	828,523	419,688	505,678	753,056
Market Cap Growth	-36.59%	-32.20%	97.41%	-17.00%	-32.85%	22.16%
Enterprise Value	537,719	600,784	959,912	491,395	649,827	873,041
Last Close Price	28950.00	29650.00	32657.14	29902.46	31049.55	35456.20
PE Ratio	8.83	9.24	22.39	13.16	-	-
PS Ratio	0.71	0.78	1.11	0.61	0.83	1.38
PB Ratio	1.55	1.71	3.12	1.86	2.68	3.63
P/TBV Ratio	1.60	1.76	3.29	1.84	2.68	3.86
P/FCF Ratio	8.28	7.90	13.84	8.96	47.45	14.86
P/OCF Ratio	7.08	7.08	9.51	7.39	27.90	11.94
EV/Sales Ratio	0.74	0.84	1.28	0.72	1.07	1.60
EV/EBITDA Ratio	5.45	5.90	8.05	6.36	13.84	45.08
EV/EBIT Ratio	6.73	7.26	9.93	8.12	21.07	-
EV/FCF Ratio	8.69	8.45	16.03	10.49	60.98	17.23
Debt / Equity Ratio	0.24	0.28	0.64	0.93	1.30	0.88
Debt / EBITDA Ratio	0.82	0.90	1.43	2.71	5.22	9.41
Debt / FCF Ratio	1.29	1.29	2.84	4.47	23.00	3.60
Asset Turnover	1.14	1.15	1.18	1.09	1.03	0.98
Inventory Turnover	3.42	3.64	3.79	3.70	3.65	3.86
Quick Ratio	0.84	0.82	0.90	0.80	0.79	0.78
Current Ratio	1.48	1.47	1.32	1.12	1.30	1.27
Return on Equity (ROE)	20.59%	21.87%	15.65%	14.41%	-0.73%	-6.98%
Return on Assets (ROA)	7.73%	8.28%	9.49%	6.00%	3.26%	-0.15%
Return on Capital (ROIC)	11.72%	12.07%	13.87%	8.70%	4.68%	-0.21%
Return on Capital Employed (ROCE)	20.00%	20.90%	27.00%	24.40%	8.80%	-
Earnings Yield	11.33%	11.58%	4.47%	7.60%	-0.19%	-2.02%
FCF Yield	12.07%	12.65%	7.23%	11.16%	2.11%	6.73%
Dividend Yield	1.64%	1.52%	-	-	-	-
Payout Ratio	15.48%	14.86%	23.82%	23.05%	-	-
Buyback Yield / Dilution	2.18%	2.01%	-2.49%	-0.07%	0.05%	-0.04%
Total Shareholder Return	3.82%	3.53%	-2.49%	-0.07%	0.05%	-0.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.